Surgery for valvular heart disease: a population-based study in a Brazilian urban center

Guilherme S Ribeiro1, Sara Y Tartof, Dalton W S Oliveira

  • 1Institute of Collective Health, Federal University of Bahia, Salvador, Bahia, Brazil. gsribeiro@ufba.br

Plos One
|June 6, 2012
PubMed

Insights

Rheumatic heart disease (RHD) is the leading cause of heart valve surgery in Salvador, Brazil, predominantly affecting young adults. Degenerative valve disease impacts the elderly, highlighting different public health needs.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Rheumatic heart disease (RHD) poses a significant burden in middle-income countries.
  • Increasing life expectancy may lead to a rise in other heart valve diseases.

Purpose of the Study:

  • To compare population-based data on surgical procedures for heart valve disease in Salvador, Brazil.
  • To assess the relative importance of different etiologies of heart valve disease.

Main Methods:

  • Review of medical charts for 491 patients undergoing valvular heart surgery (2002-2005).
  • Calculation of incidence rates for valvular heart disease surgeries.
  • Logistic regression analysis to identify factors associated with in-hospital mortality.

Main Results:

  • Rheumatic heart disease (RHD) was the most common cause (60.3%) of valvular heart surgery, primarily in young adults and publicly funded.
  • Degenerative valve disease accounted for 15.3% of surgeries, predominantly in those over 60 and privately funded.
  • In-hospital mortality was 11.9%, with increased age, endocarditis, multiple procedures, and prior surgery being significant risk factors.

Conclusions:

  • RHD remains the primary indication for heart valve surgery in Salvador, affecting younger, uninsured populations.
  • Degenerative valve disease is more prevalent in older, privately insured individuals.
  • Targeted strategies are needed to address the distinct causes and patient demographics of RHD and degenerative valve disease.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...